© 1995 American Heart Association, Inc.
Articles |
Procoagulant Human Monocytes Mediate Tissue Factor/Factor VIIa–Dependent Platelet-Thrombus Formation When Exposed to Flowing Nonanticoagulated Human Blood
From Nycomed Bioreg AS and the Department of Clinical Chemistry, Ulleval University Hospital (P.K., A.-B.W), Oslo, Norway.
Correspondence to R. Marius Barstad, MD, Nycomed Bioreg AS, Gaustadalléen 21, N-0371 Oslo, Norway.
Abstract Tissue factor (TF) on monocyte and macrophage surfaces is a nonproteolytic cofactor for factor VIIa (FVIIa)–induced coagulation. Monocyte-derived macrophages in atherosclerotic plaques express TF, which, after plaque disruption or rupture, may complex with FVII/VIIa from the bloodstream, resulting in activation of extrinsic coagulation. We studied the effect of TF expression on human monocytes on arterial thrombus formation in a model system of thrombogenesis. Thawed, cryopreserved human monocytes adherent to plastic coverslips were stimulated with lipopolysaccharide (0.5 µg/mL) to express TF and subsequently exposed to flowing nonanticoagulated human blood in a parallel-plate perfusion chamber. The wall shear rate at the cell surface was 650 seconds-1, corresponding to that of average-sized coronary arteries. The stimulated monocytes elicited pronounced fibrin deposition and platelet-thrombus formation. The platelet-thrombus volume was as large as that triggered by human type III collagen fibrils under similar experimental conditions. In contrast, the monocytes elicited much more fibrin deposition than the collagen surface. However, inclusion of an anti-TF monoclonal antibody that blocks the complexation of FVII/FVIIa with TF virtually abolished the fibrin deposition (P<.03) and reduced platelet-thrombus formation by more than 70% (P<.04). Thus, arterial thrombus formation induced by stimulated monocytes was almost completely blocked by the anti-TF antibody, suggesting that inhibition of TF/FVIIa complex formation on monocytes and macrophages at sites of plaque rupture or after percutaneous transluminal coronary angioplasty procedures may reduce intravascular thrombotic complications.
Key Words: thrombosis model • procoagulant monocytes • tissue factor • fibrin deposition • platelet-thrombus formation
This article has been cited by other articles:
 |
|
 |
|
  M. Takano, S. Inami, F. Ishibashi, K. Okamatsu, K. Seimiya, T. Ohba, S. Sakai, and K. Mizuno Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions J. Am. Coll. Cardiol., March 1, 2005; 45(5): 652 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujii, Y. Kobayashi, G. S. Mintz, H. Takebayashi, G. Dangas, I. Moussa, R. Mehran, A. J. Lansky, E. Kreps, M. Collins, et al. Intravascular Ultrasound Assessment of Ulcerated Ruptured Plaques: A Comparison of Culprit and Nonculprit Lesions of Patients With Acute Coronary Syndromes and Lesions in Patients Without Acute Coronary Syndromes Circulation, November 18, 2003; 108(20): 2473 - 2478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nieuwland, R. J. Berckmans, S. McGregor, A. N. Boing, F. P. H. Th. M. Romijn, R. G. J. Westendorp, C. E. Hack, and A. Sturk Cellular origin and procoagulant properties of microparticles in meningococcal sepsis Blood, February 1, 2000; 95(3): 930 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Turner, M. Gosling, J. T. Powell, and J. Golledge Rapid Changes in the Coagulant Proteins on Saphenous Vein Endothelium in Response to Arterial Flow Angiology, September 1, 1999; 50(9): 693 - 701. [Abstract] [PDF]
|
|
|
|
|
|
S. D. Gertz, J. T. Fallon, R. Gallo, M. B. Taubman, S. Banai, W. L. Barry, L. W. Gimple, Y. Nemerson, S. Thiruvikraman, S. S. Naidu, et al. Hirudin Reduces Tissue Factor Expression in Neointima After Balloon Injury in Rabbit Femoral and Porcine Coronary Arteries Circulation, August 11, 1998; 98(6): 580 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Orvim, R. M. Barstad, L. Orning, L. B. Petersen, M. Ezban, U. Hedner, and K. S. Sakariassen Antithrombotic Efficacy of Inactivated Active Site Recombinant Factor VIIa Is Shear Dependent in Human Blood Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3049 - 3056. [Abstract] [Full Text]
|
|
|
|
|
|
K. Kaikita, H. Ogawa, H. Yasue, M. Takeya, K. Takahashi, T. Saito, K. Hayasaki, K. Horiuchi, A. Takizawa, Y. Kamikubo, et al. Tissue Factor Expression on Macrophages in Coronary Plaques in Patients with Unstable Angina Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2232 - 2237. [Abstract] [Full Text]
|
|
|
|
|
|
V. Toschi, R. Gallo, M. Lettino, J. T. Fallon, S. D. Gertz, A. Fernandez-Ortiz, J. H. Chesebro, L. Badimon, Y. Nemerson, V. Fuster, et al. Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques Circulation, February 4, 1997; 95(3): 594 - 599. [Abstract] [Full Text]
|
|
|
|
|
|
J.-C. Reverter, D. Tassies, J. Font, J. Monteagudo, G. Escolar, M. Ingelmo, and A. Ordinas Hypercoagulable State in Patients With Antiphospholipid Syndrome Is Related to High Induced Tissue Factor Expression on Monocytes and to Low Free Protein S Arterioscler. Thromb. Vasc. Biol., November 1, 1996; 16(11): 1319 - 1326. [Abstract] [Full Text]
|
|